非隐蔽安慰剂治疗绝经期潮热:随机对照试验研究方案
这是一项评估者盲法随机对照试验,纳入100名每日至少5次中重度潮热的围绝经期和绝经后女性,按1:1分配至4周开放标签安慰剂治疗组或不治疗组,主要结局为治疗后潮热复合评分和潮热烦恼程度评分。开放标签安慰剂组再次随机分为继续或停止治疗4周以探索安慰剂效应的持续和维持,数据采用(广义)线性混合模型分析。
要点
- 开放标签安慰剂治疗与不治疗相比,对围绝经期和绝经后女性潮热复合评分及烦恼程度的影响将在本试验中评估。
- 试验纳入每日至少5次中重度潮热的围绝经期和绝经后女性,开放标签安慰剂组在4周后再次随机分为继续或停止治疗4周。
- 主要结局为治疗后潮热复合评分(频率×严重程度)和潮热烦恼程度(Hot Flush Rating Scale),采用(广义)线性混合模型分析。
核心结论
- 该试验将有助于评估开放标签安慰剂治疗在临床实践中的应用,并加深对潮热治疗中安慰剂效应大小的理解。
研究设计与样本
- 评估者盲法随机对照试验,纳入100名每日至少5次中重度且令人烦恼的潮热的围绝经期和绝经后女性,按1:1分配至4周开放标签安慰剂治疗组或不治疗组。
- 开放标签安慰剂组在4周后再次随机分为继续或停止开放标签安慰剂治疗4周,以探索安慰剂效应的持续和维持。
- 所有参与者接受关于安慰剂效应的简要介绍,并在基线、治疗后(4周)和随访(8周,仅开放标签安慰剂组)进行研究访视,同时进行关于开放标签安慰剂治疗主观体验的定性访谈。
- 数据采用(广义)线性混合模型分析,并利用随访数据进行维持和持续时间的探索性分析。
局限性
- 试验注册为回顾性注册(Clinicaltrials.gov,NCT03838523,2019年2月12日回顾性注册),首例患者于2018年10月10日入组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Beneficial effects of placebos are high in double-blind hot flush trials. Studies in various conditions suggest that honestly prescribed placebos may elicit symptom improvement. OBJECTIVE: To determine whether open label placebo (OLP) treatment is efficacious in alleviating hot flushes among peri- and postmenopausal women. METHODS/DESIGN: In this assessor-blinded, randomized-controlled trial, n = 100 women experiencing five or more daily hot flushes of at least moderate severity and bothersomeness are assigned 1:1 to a 4-week OLP treatment or no treatment. To explore the duration and maintenance of placebo effects, the OLP group is randomized a second time to either discontinue or continue the OLP treatment for another 4 weeks. All participants receive a briefing about placebo effects and study visits at baseline, post-treatment (4 weeks), and follow-up (8 weeks, OLP group only). Qualitative interviews about subjective experiences with the OLP treatment are conducted. Primary outcomes are differences between the OLP and the no-treatment group in the hot flush composite score (frequency × severity), and bothersomeness of hot flushes as assessed with the Hot Flush Rating Scale at post-treatment. Secondary outcomes include hot flush frequency, health-related quality of life, global improvement, and the number of responders at post-treatment. Data are analyzed by fitting (generalized) linear mixed models. An exploratory analysis of maintenance and duration is performed including follow-up data. DISCUSSION: This trial will contribute to the evaluation of OLP treatments in clinical practice and further our understanding about the magnitude of placebo effects in hot flush treatments. TRIAL REGISTRATION: Clinicaltrials.gov, NCT03838523 . Retrospectively registered on February 12th, 2019. The first patient was enrolled on October 10th, 2018.
引用
- Pan Y, Meister R, Löwe B, et al. Non-concealed placebo treatment for menopausal hot flushes: Study protocol of a randomized-controlled trial. Trials. 2019. PMID: 31420050. doi:10.1186/s13063-019-3575-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。